Pancreatic ductal adenocarcinoma (PDAC) accounts for more than 90% of all pancreatic cancer cases [9] and activating hotspot mutations in the KRAS gene are present in the majority of them, representing the most frequent [10] but also the earliest genetic alteration that drives pancreatic neoplasia [11–13]. This evidence concerns the gene KRAS and pancreatic neoplasm.